| scholarly article | Q13442814 |
| P50 | author | Alicia Beeghly-Fadiel | Q88082688 |
| Qiuyin Cai | Q59194517 | ||
| Yu-Tang Gao | Q73862394 | ||
| P2093 | author name string | Wei Zheng | |
| Jirong Long | |||
| Neeraja B Peterson | |||
| Xiao-ou Shu | |||
| P2860 | cites work | Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay | Q24557419 |
| The structure of haplotype blocks in the human genome | Q27860500 | ||
| The International HapMap Project | Q27860695 | ||
| Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population | Q81482268 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 | Q28185858 | ||
| New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
| Multiple roles of matrix metalloproteinases during apoptosis. | Q33340888 | ||
| Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis | Q34013787 | ||
| Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
| Matrix metalloproteinases: they're not just for matrix anymore! | Q34360566 | ||
| Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression | Q34573212 | ||
| Complex roles of tissue inhibitors of metalloproteinases in cancer | Q34596110 | ||
| Roles of matrix metalloproteinases in tumor metastasis and angiogenesis | Q35051145 | ||
| Matrix metalloproteinases and tumor progression | Q35195972 | ||
| Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development | Q35581768 | ||
| Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome | Q35605873 | ||
| Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis | Q35842033 | ||
| Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. | Q35878888 | ||
| Integrative epidemiology: from risk assessment to outcome prediction | Q36002142 | ||
| Understanding breast cancer risk -- where do we stand in 2005? | Q36077410 | ||
| Novel functions of TIMPs in cell signaling | Q36471132 | ||
| A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. | Q37161006 | ||
| Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast | Q37206817 | ||
| Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study | Q39540042 | ||
| Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. | Q42280122 | ||
| Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1. | Q42469568 | ||
| Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. | Q45876182 | ||
| Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas | Q46972482 | ||
| Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. | Q51961781 | ||
| High levels of TIMP-2 correlate with adverse prognosis in breast cancer. | Q52141709 | ||
| Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. | Q54633524 | ||
| High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases | Q58897956 | ||
| Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation | Q72102660 | ||
| Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study | Q73340593 | ||
| Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes | Q79266982 | ||
| Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans | Q79889095 | ||
| The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer | Q81453672 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 844-850 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival | |
| P478 | volume | 125 |
| Q53350461 | Analysis of the association between polymorphisms in MMP2, MMP3, MMP9, MMP20, TIMP1, and TIMP2 genes with white spot lesions and early childhood caries. |
| Q38458366 | Association between MMP-2 and TIMP-2 gene polymorphisms and advanced-stage endometriosis in Korean women |
| Q64055300 | Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women |
| Q50052994 | Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population |
| Q36287441 | Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population |
| Q39790504 | Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q36192139 | Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women |
| Q61444486 | DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats |
| Q38101685 | Does mammographic density reflect the expression of breast cancer markers? |
| Q35739981 | Gene-gene interactions between TGF-β/Smad3 signalling pathway polymorphisms affect susceptibility to knee osteoarthritis |
| Q34634735 | Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction |
| Q50863404 | Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. |
| Q34242914 | Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival |
| Q83304699 | Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study |
| Q47607004 | MMP13 polymorphism decreases risk for dental caries |
| Q36299328 | Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer |
| Q64057740 | Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study |
| Q37702061 | TIMP-2 SNPs rs7342880 and rs4789936 are linked to risk of knee osteoarthritis in the Chinese Han Population |
| Q88027699 | TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women |
| Q92277219 | TIMP-3 as a therapeutic target for cancer |
Search more.